Ethical Considerations for the Inclusion of Patient-Reported

These international, consensus-based, patient-reported outcomes (PRO)–specific guidelines aim to lay out the ethical considerations that researchers, research e

Related Keywords

Helsinki , Eteläuomen Läi , Finland , Japan , Tokyo , Facit , Lancashire , United Kingdom , Nuffield , Oxfordshire , Edgbaston , Birmingham , Canada , West Midlands , United Kingdom General , Canadian , Amanda Hunn , Daiichi Sankyo , Haf Davies , Melaniej Calvert , Cruz Rivera , Glaxosmithkline , Research Council Experimental Medicine , Nipro Corp , Japan Media Corp , Language Summaries For The Research Participants , Astrazeneca , International Delphi , Birmingham Health Partners Centre For Regulatory Science , Birmingham Biomedical Research Centre , National Institutes Of Health , Clinical Academic Program Doctoral Research Fellowship , Medrio Inc , Welby Inc , Urogen Pharma Ltd , Regulatory Agency , International Society For Quality Of Life Research , Department Of Clinical Trial Data Management , Gilead Sciences Ltd , Microbiology Research Centre , Institute Of Applied Health Research , Association Of Community Cancer Centers , Linkedin , Veloxis Pharmaceuticals , Research Collaboration West Midlands , Health Foundation , Transparency Of Health Research , Mode Of Administration , Takeda Pharmaceutical Co , University Of Birmingham Ethical Review Board , Aparito Ltd , Health Research Authority , Aetion Inc , European Medicines Agency , Health Education England , Care Research , Canadian Interagency Panel On Research Ethics , Pfizer Japan Inc , Amgen , Vaccines Expert Advisory Group , National Cancer Institute , Members Of The Public Been Incorporated , Pfizer , International Consensus Meeting , Input Has Not Been Sought Or Incorporated , Ethics Operations Group , Department Of Health , Deceased Donor Family Tissue Advisory Group , Japan Tobacco Inc , Research Foundation , Ethics Steering Group , Faron Pharmaceuticals , European Regional Development Fund , Canadian Institutes Of Healthcare Research , United Kingdom Research , Health Literature , Drug Administration , Henry Ford Cancer Center , National Institute For Health , Centre For Patient Reported Outcome Research , Core Outcome Measures In Effectiveness Trials Initiative , Medidata Solutions , Defence Medical Services , Health Data Research United Kingdom , School Of Medicine , Genentech , Regulatory Agency Clinical Trials , Twitter , Cancer Research United Kingdom Clinical Committee , Purchaser Business Group On Health , University Of Birmingham , Foundation Fellowship , Nuffield Bioethics Working Group , Council Policy Statement , Bristol Myers Squibb , University Hospitals Birmingham , Overall Health , Ethical Conduct For Research Involving Humans , Peterg Peterson Foundation , University Of Warwick , University Of Tokyo , Outcomes Research Institute , Johnson , Council For International Organizations Of Medical Sciences , Health Research , Standard Protocol Items , Interventional Trials , Steering Group , Birmingham Ethical Review Board , Candidate Items , Complementary Medicine Database , Cumulative Index , Allied Health Literature , Delphi Process , Operations Group , Core Outcome Measures , Effectiveness Trials , Consensus Meeting , Voting Process , Specific Research , How Clearly Are , Are Any , Specific Eligibility Requirements Identified , Literacy Requirements , How Clearly Have These Been , Overall Health Related Quality , Specific Domain , Specific Symptom , Instruments Have Been , How Has , Change From Baseline , Final Value , Principal Time Point , Been Specified , How Well Does , Participant Information Sheet Provide , Primary End Point , What Justification Is Provided , Data Collection , What Details About , Data Collection Plan Have Been Provided , Permitted Mode , Concerning Responses Will Occur During , How Will This Inform , Clinical Care , Individual Study , How Have Barriers , Cultural Needs , Been Minimized , Promote Participant , How Has Participant Acceptability , Burden Been Described , Contexts Where Participants Are Not Able , May Become Unable , How Will , Proxy Reporting , How Has Input From Patient Partners , Public Been Incorporated , Input Has Not Been Sought , How Has This Been , Symptom Burden Questionnaire , What Mechanisms Have Been Introduced , Minimize Missing , How Have These Been Explained , Follow Up Calls , What Dissemination Plans , Plain Language Summaries , Research Participants , Care Proposed , Belmont Report , International Organizations , Medical Sciences , Tri Council Policy Statement , Ethical Conduct , Research Involving , Box Section Ref , Patient Reported Outcome Research , Applied Health Research , Drs Cruz Rivera , Interest Disclosures , Demand Hub , National Institute , Birmingham Women , Transplant Deceased Donor Family Tissue Advisory , Drs Ells , Canadian Interagency Panel , Research Ethics , Canadian Tri Council Policy Statement , Health Education , Clinical Trial Data Management , Graduate School , New Age Trading , Ono Pharmaceutical , Medi Solution , Ayumi Pharmaceutical , National Institutes , Northwestern University George , Brien Kidney Core , International Society , Life Research , Clovis Oncology ,